Keyphrases
Accessory Pathway
20%
Acute Myocardial Infarction
34%
Adenosine Triphosphate
29%
Amiodarone
21%
Antiarrhythmic Drugs
25%
Arrhythmia
73%
Arrhythmic Storm
17%
Atrial Fibrillation
22%
Atrioventricular Block
26%
Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
20%
AV Nodal Reentrant Tachycardia
21%
Bedside Test
16%
Beta-blockers
40%
Brugada Syndrome
95%
Cardiac Arrest
25%
Catecholaminergic Polymorphic Ventricular Tachycardia
23%
Catheter
26%
Clinical Characteristics
19%
Congenital Long QT Syndrome
44%
Consecutive Patients
17%
Defibrillator
20%
Early Repolarization
20%
Electrophysiologic
30%
Electrophysiological Study
36%
Exercise-induced
16%
Flecainide
21%
Genotype
17%
Healthy Controls
17%
Healthy Individuals
21%
Heart Rate
26%
Idiopathic Ventricular Fibrillation
68%
Implantable Defibrillator
39%
Left Bundle Branch Block
15%
Long QT Syndrome
100%
Myocardial Infarction
38%
Non-invasive Diagnosis
15%
Polymorphic Ventricular Tachycardia
45%
QT Interval
47%
QT Prolongation
23%
Quinidine
38%
Radiofrequency Ablation
37%
Risk Stratification
24%
Sinus Rhythm
26%
Sudden Death
38%
Supraventricular Tachycardia
18%
Syncope
24%
Torsades Des Pointes
63%
Ventricular Arrhythmia
60%
Ventricular Fibrillation
64%
Ventricular Tachycardia
35%
Medicine and Dentistry
Accessory Pathway
19%
Adenosine Triphosphate
24%
Amiodarone
18%
Antiarrhythmic Agent
24%
Athletes
13%
Atrial Fibrillation
24%
Atrioventricular Nodal Reentry Tachycardia
19%
Brugada Syndrome
77%
Cardiac Dysrhythmia
54%
Cardiac Resynchronization Therapy
14%
Cardiovascular System
11%
Catheter Ablation
10%
Cellular Mechanism
9%
Congestive Heart Failure
17%
Defibrillator
40%
Diseases
14%
Ejection Fraction
11%
Electrocardiogram
35%
Faintness
26%
Heart Arrest
25%
Heart Disease
18%
Heart Ventricle Arrhythmia
42%
Idiopathic Ventricular Fibrillation
65%
Implantable Automatic Defibrillator
39%
J Wave
18%
Left Bundle Branch Block
15%
Long QT Syndrome
47%
Magnesium Sulfate
9%
Monomorphic Ventricular Tachycardia
20%
Mortality Rate
15%
Myocardial Infarction
24%
Palpitations
9%
Polymorphic Ventricular Tachycardia
33%
Prevalence
12%
Pulmonary Vein
12%
Pulmonary Vein Isolation
12%
QT Interval
18%
QT Prolongation
11%
Quinidine
17%
Radiofrequency Ablation
36%
Repolarization
39%
Risk Stratification
23%
Sinus Rhythm
17%
Sudden Cardiac Death
13%
Sudden Death
30%
Supraventricular Tachycardia
17%
T Wave
10%
Torsade Des Pointes
18%
Ventricular Fibrillation
63%
Ventricular Tachycardia
56%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Infarction
33%
Adenosine
6%
Adenosine Triphosphate
14%
Amiodarone
13%
Antiarrhythmic Agent
14%
Antiarrhythmic Drug
6%
Arrhythmogenesis
5%
Atrial Fibrillation
20%
Atrioventricular Block
16%
Atrioventricular Nodal Reentry Tachycardia
10%
Beta Adrenergic Receptor Blocking Agent
13%
Brugada Syndrome
39%
Calcium Channel Blocker
7%
Catecholaminergic Polymorphic Ventricular Tachycardia
16%
Clinical Trial
7%
Faintness
17%
Flecainide
18%
Heart Arrest
13%
Heart Arrhythmia
60%
Heart Disease
12%
Heart Infarction
28%
Heart Ventricle Arrhythmia
40%
Heart Ventricle Extrasystole
5%
Heart Ventricle Fibrillation
80%
Heart Ventricle Tachycardia
45%
Infarction
8%
Ischemia
10%
Ischemic Heart Disease
11%
Long QT Syndrome
66%
Long QT Syndrome 3
10%
Monomorphic Ventricular Tachycardia
6%
Mortality Rate
5%
Normal Human
14%
Paroxysmal Atrial Fibrillation
9%
Paroxysmal Supraventricular Tachycardia
7%
Polymorphic Ventricular Tachycardia
21%
Population Study
6%
QT Prolongation
8%
Quinidine
31%
Ranolazine
9%
Recurrent Disease
8%
Sodium Channel
5%
Sudden Cardiac Death
5%
Sudden Death
19%
Supraventricular Tachycardia
13%
Syndrome
10%
Tachycardia
9%
Thorax Pain
5%
Torsade Des Pointes
44%
Verapamil
10%